PD-RX Pharmaceuticals (PDRX) Stock Price

PD-RX Pharmaceuticals Price

OTC·CLOSED
3.10
​
Market closed

PD-RX Pharmaceuticals stock price

Access this data via the Eulerpool API

PD-RX Pharmaceuticals business model & stock analysis

PD-Rx Pharmaceuticals, Inc. engages in the pharmaceutical services business. The company is headquartered in Oklahoma City, Oklahoma. The company went IPO on 2001-12-17. The firm was founded in 1995.

Frequently asked questions about PD-RX Pharmaceuticals

The revenue cannot currently be calculated for PD-RX Pharmaceuticals.

The profit cannot currently be calculated for PD-RX Pharmaceuticals.

The P/E ratio cannot be calculated for PD-RX Pharmaceuticals at the moment.

The P/S cannot be calculated for PD-RX Pharmaceuticals currently.

The Eulerpool Quality Score for PD-RX Pharmaceuticals is 0/10.

The ISIN of PD-RX Pharmaceuticals is US6932981011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of PD-RX Pharmaceuticals is PDRX. The ticker symbol is used to trade PD-RX Pharmaceuticals shares on the stock exchange.

Fair ValueTerminal
2.88
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website pdrx.com
Currency
Initial public offering
Dec 17, 2001
ISIN
US6932981011
Cusip
693298101
Market capitalization
4.79 M Micro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
—
ROA (Return on Assets)
—
ROCE (Return on Capital Employed)
—
ROIC (Return on Invested Capital)
—
Last updated Oct 10, 2026, 1:41 PM

PD-RX Pharmaceuticals Peer Group

PD-RX Pharmaceuticals Ticker

OTC · PDRX

PD-RX Pharmaceuticals FIGI

PDRX:US · BBG000C1NGF6PDRX:PQ · BBG000C1NNL4PDRX:UV · BBG000C1NPY5

All fundamentals and in-depth analysis of PD-RX Pharmaceuticals

Our stock analysis for PD-RX Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PD-RX Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.